Brief: Vericel Announces FDA Approval Of Nexobrid For The Treatment Of Severe Thermal Burns In Adults

Vericel

29/12/2022 18:46

Dec 29 (Reuters) - Vericel Corp  VCEL.O :
    * VERICEL ANNOUNCES FDA APPROVAL OF NEXOBRID FOR THE TREATMENT OF SEVERE
THERMAL
BURNS IN ADULTS
    * VERICEL CORP - NEXOBRID IS ANTICIPATED TO BE COMMERCIALLY AVAILABLE IN
U.S. IN
Q2 OF 2023
    * VERICEL CORP - NEXOBRID STUDY MET ITS PRIMARY ENDPOINT OF COMPLETE ESCHAR
REMOVAL AS WELL AS ALL SECONDARY ENDPOINTS

Source text for Eikon:  ID:nGNX9KdP5v 
Further company coverage:  VCEL.O 
 ((Reuters.Briefs@thomsonreuters.com;))